Compiled by Bill Beggs jr.
FOR INCLUSION IN TECH TALK: Please e-mail your tech information as a press release to: meg@sggdesign.com
The monthly technology column featuring timely tech trends, tips and updates.
Advanced ICU Care
Raises $5 Million in Funding
Advanced ICU Care, which delivers board-certified intensivists and nurses to hospital ICU patients via telemedicine, has closed on a series B funding round to support continued growth.
The company's eICU telemedicine technology allows intensivists and critical-care nurses to monitor nearly 100 ICU beds located in 10 hospitals across five states. The second round of financing will help Advanced ICU Care continue to expand.
The company estimates that 8,100 intensivists serve 4.4 million ICU patients nationwide, and touts its program as a way to
alleviate the shortage of these
specialized physicians.
SLU Studies Experimental
Smallpox Vaccine for Eczema Patients
Saint Louis University School of Medicine researchers are preparing to test an experimental smallpox vaccine on people with atopic dermatitis (eczema), whose skin disorder may put them at higher risk for
side effects.
Imvamune, containing a weakened virus that can't grow or replicate in humans, has been tested so far on nearly 2,000 people, including those with atopic dermatitis or HIV.
Smallpox is a highly contagious infectious disease that can cause a severe skin eruption, blindness and later death. Though declared eradicated in 1979, experts fear clandestine samples of the virus may have survived—a major bioterrorism concern.
PixelEXX to Use Nanotechnology for Cancer and Drug Research
Nanoarrays are the key concept behind PixelEXX Systems, a company founded by Washington University with the support of BioGenerator, a non-profit that facilitates the formation of plant and life
science companies.
PixelEXX plans to bring imaging nanoarrays to market. Nano-sized sensors generate a real-time picture of a living cell, its internal structures and how they function.
One product could be a solid-state device combining the features and capabilities of much larger, more-expensive tools such as the electron microscope. Another could be nanosensor arrays for high-throughput screening of drug candidates.
|
